Latest filing published 22 Oct 2026 for Bio-Rad Laboratories, INC..
All filings by Sedat Evran on record concern Bio-Rad Laboratories, Inc. Between 20 October 2024 and 20 October 2026, the trades on record add up to 12 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 22 October 2026 came the latest disclosure, an option exercise in Bio-Rad Laboratories, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations